HomeBAVA • CPH
add
Bavarian Nordic A/S
Nakaraang pagsara
kr 185.20
Sakop ng araw
kr 184.20 - kr 187.80
Sakop ng taon
kr 125.55 - kr 194.00
Market cap
14.47B DKK
Average na Volume
405.25K
P/E ratio
-
Dividend yield
-
Primary exchange
CPH
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (DKK) | Mar 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 831.47M | -33.59% |
Gastos sa pagpapatakbo | 394.13M | -13.17% |
Net na kita | -114.45M | -130.41% |
Net profit margin | -13.76 | -145.78% |
Kita sa bawat share | -1.50 | -129.41% |
EBITDA | 21.84M | -95.46% |
Aktuwal na % ng binabayarang buwis | -0.27% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (DKK) | Mar 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 2.29B | -22.87% |
Kabuuang asset | 13.62B | 3.34% |
Kabuuang sagutin | 3.45B | -15.11% |
Kabuuang equity | 10.17B | — |
Natitirang share | 76.30M | — |
Presyo para makapag-book | 1.39 | — |
Return on assets | -2.30% | — |
Return on capital | -3.10% | — |
Cash Flow
Net change in cash
| (DKK) | Mar 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -114.45M | -130.41% |
Cash mula sa mga operasyon | 435.23M | 302.72% |
Cash mula sa pag-invest | -1.05B | -415.81% |
Cash mula sa financing | -10.73M | -101.84% |
Net change in cash | -616.42M | -188.53% |
Malayang cash flow | 1.25B | 475.41% |
Tungkol
Bavarian Nordic A/S is a fully integrated biotechnology company focused on the development, manufacturing and commercialization of vaccines. The company is headquartered in Hellerup, Denmark, with a manufacturing facility in Kvistgård, and an additional site in Hørsholm. The company has a research and development facility in Martinsried, Germany, and offices in Zug, Switzerland, and Morrisville, North Carolina. The company uses viral vectors in its research and development. Wikipedia
CEO
Itinatag
Hul 1, 1992
Website
Mga Empleyado
1,381
